Screener
Xenon Pharmaceuticals XENE Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$110.74M-30.7% | -$102.3M-57.3% | -$105.26M-60.3% | -$90.9M-44.8% | -$84.71M-46.2% | ||
| $558K-11.7% | $587K-10.9% | $611K-8.3% | $641K-3.9% | $632K-1.4% | ||
| $16.73M+22.0% | $16.89M+38.8% | $14.12M+3.8% | $13.71M+5.4% | $13.71M-6.8% | ||
| -$95.39M-48.5% | -$88.9M-44.2% | -$81.48M-49.8% | -$71.75M-44.5% | -$64.23M-106% | ||
| $275K+75.2% | $133K+209% | $318K-59.4% | $281K-52.4% | $157K-89.6% | ||
| -$331.24M-503% | -$407.28M-1,280% | $62.7M-36.4% | $38.53M+7,637% | $82.26M-24.7% | ||
| $26K-60.0% | $843.01M+73,142% | $113.54M+836% | $2.36M— | $65K— | ||
| -$426.34M-2,377% | $346.7M+1,431% | $94.65M— | -$30.87M+37.2% | $18.72M— | ||
| -$95.67M-48.6% | -$89.03M-44.3% | -$81.8M-48.3% | -$72.03M-43.3% | -$64.39M-97.1% |
FAQ
- How much cash does Xenon Pharmaceuticals generate?
- Xenon Pharmaceuticals (XENE) generated -$337.5M in operating cash flow over the trailing twelve months.
- What is Xenon Pharmaceuticals's free cash flow?
- After $1.0M of capital expenditures, Xenon Pharmaceuticals's free cash flow was -$338.5M over the trailing twelve months, down 46.2% year over year.
- Where does Xenon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Xenon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.